Sandbox/Bites: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 48: Line 48:
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Amoxicillin-clavulanate]] 875/125 mg orally q12h X 5 days'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Amoxicillin-clavulanate]] 875/125 mg orally q12h X 5 days'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen (beta-lactam allergy)'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left | ▸ '''''[[Moxifloxacin]] 400 mg orally q6h AND [[Clindamycin]] 300 mg orally q6h'''''<BR> OR <BR> ▸ '''''[[Trimethoprim-sulfamethoxazole]] 1 double-strength tablet orally q12h AND [[metronidazole]] 250 to 500 mg orally q6h'''''
|-
|-
|}
|}

Revision as of 16:19, 21 May 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Cellulitis Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Cellulitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox/Bites On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox/Bites

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox/Bites

CDC on Sandbox/Bites

Sandbox/Bites in the news

Blogs on Sandbox/Bites

Directions to Hospitals Treating Cellulitis

Risk calculators and risk factors for Sandbox/Bites

Empiric Therapy

▸ Click on the following categories to expand treatment regimens.

Human Bites

  ▸  Adults

  ▸  Children

  ▸  Animal Bites

  ▸  Insect Bites

Early (not yet infected)
Preferred Regimen
Amoxicillin-clavulanate 875/125 mg orally q12h X 5 days
Alternative Regimen (beta-lactam allergy)
Moxifloxacin 400 mg orally q6h AND Clindamycin 300 mg orally q6h
OR
Trimethoprim-sulfamethoxazole 1 double-strength tablet orally q12h AND metronidazole 250 to 500 mg orally q6h
Late (infected)
Preferred Regimen
Ampicillin sulbactam 1.5 gm IV q6h
OR
Cefoxitin 2 gm IV q8h
OR
Ticarcillin clavulanate 3.1 gm IV q6h
OR
Piperacillin-tazobactam 3.375 gm IV q6h or 4.5 gm q8h or 4-hr infusion of 3.375 gm q8h
Alternative Regimen
Clindamycin 1.5 gm IV q6h
PLUS
Trimethoprim sulphamethaxole
OR
Cefepime
Early (not yet infected)
Preferred Regimen
Amoxicillin-clavulanate (> 12weeks) 45 mg/kg/day orally in 2 divided doses for 5 days
Late (infected)
Preferred Regimen
Ampicillin sulbactam 100 to 300 mg/kg/day IV q6h
OR
Cefoxitin 80 to 160 mg/kg/day IV in 4 divided doses
OR
Ertapenem (3months - 12years) 15 mg/kg IV twice daily (maximum 1 g/day) OR Ertapenem (>13years) 1 g IV once daily
Rat
Preferred Regimen
Amoxicillin-clavulanate 875/125 mg orally q12h X 5 days
Pig (Swine)
Preferred Regimen
Amoxicillin-clavulanate 875/125 mg orally q12h X 5 days
Alternative Regimen
Ampicillin sulbactam
OR
Imipenem
OR
Cephalosporin
Monkey bite
Preferred Regimen (without CNS symptoms)
Acyclovir 12.5–15 mg per kg IV q8h
OR
Ganciclovir 5 mg per kg IV q12h
Preferred Regimen (with CNS symptoms)
Ganciclovir 5 mg per kg IV q12h
Oral Regimen
Clindamycin 5 mg/kg orally q8h
OR
Linezolid 10 mg/kg orally q8-12h
Parental Regimen
Vancomycin 10 to 15 mg/kg IV q8-12h
PLUS
Cefotaxime 50 mg/kg IV q8h
OR
Gentamicin 2.5 mg/kg IV q8-12h
Oral Regimen
Clindamycin 5 mg/kg orally q8h
OR
Linezolid 10 mg/kg orally q8h
Parental Regimen
Vancomycin 10 to 15 mg/kg IV q6-8h
PLUS
Cefotaxime 50 mg/kg IV q6-8h
OR
Gentamicin 2.5 mg/kg IV q8h
Oral Regimen
Clindamycin 5 mg/kg orally q6h
OR
Linezolid 10 mg/kg orally q8h

References


Template:WikiDoc Sources